Quark’s global ambitions

How Quark, GF Securities plan to deploy their $500M life sciences fund

After getting its toes wet with a couple of biotech seed investments and hiring a drug development veteran as partner and CEO, Canadian VC Quark Venture Inc. teamed up with GF Securities Co. Ltd. (SZSE:000776; HKSE:1776) to raise and manage a $500 million fund.

The partners closed the first $100 million of the Global Health

Read the full 548 word article

User Sign In